List of accepted abstracts for 20th International eSymposium

If your abstract is there in the list below, start preparing your e-poster and a 3-minute video presentation. Download and use the following ePoster template to prepare your ePoster.

  1. A Comprehensive Journey from Hot Melt Extrusion to Pharmaceutical 3D Printing.
  2. ACHIEVING IN-VIVO SYNERGY THROUGH TARGETED, RATIOMETRIC CO-DELIVERY OF ANTICANCER AGENTS WITH CO-LOADED NLCs: EVALUATION IN LUNG CARCINOMA
  3. Actively Targeted Lipopolymeric Nanoplexes for the Delivery of CRISPR/Cas9 Components for Genome Surgery
  4. Acute Toxicity Studies of Biodegradable Polymeric Based Long Acting Depot Formulation
  5. AMELIORATIVE EFFECT OF HYALURONIC ACID ON TOPICAL NANOGEL OF KETOCONAZOLE.
  6. APPLICATION OF POLYVINYL ALCOHOL FOR SOLUBILITY ENHNACEMNET OF POORLY SOLUBLE TICAGRELOR BY HOT MELT EXTRUSION
  7. Application of SeDeM & SeDeM-ODT Expert System for development of orodispersible tablets
  8. BIOADHESIVE FLUCONAZOLE MICROSPONGES LOADED FILM FOR VAGINAL INSERTION
  9. BIOGENIC SYNTHESIS OF ZINC OXIDE NANOPARTICLES USING MUSHROOM FUNGUS: CHARACTERIZATION AND MECHANISTIC INSIGHTS OF THERAPEUTIC INVESTIGATION
  10. BIOSYNTHESIS OF ZINC OXIDE NANOPARTICLES USING BIOACTIVES
  11. CATIONIC NANOSTRUCTURED LIPID CARRIERS OF BESIFLOXACIN FOR OCULAR DRUG DELIVERY
  12. CHITOSAN BASED POLYELECTROLYTE COMPLEXES FOR NASAL DRUG DELIVERY
  13. Chitosan Based Polymeric Nanoparticles of Anticancer Drug Pomalidomide
  14. CHITOSAN OLIGOSACCHARIDE LACTATE CONJUGATED PLURONIC F127 MICELLES ENCAPSULATING GATIFLOXACIN AS AN EFFECTIVE TREATMENT REGIMEN FOR BACTERIAL KERATITIS
  15. CHITOSAN/POLOXAMER-BASED MIXED MICELLES FOR OCULAR MOXIFLOXACIN DELIVERY IN BACTERIAL KERATITIS
  16. COMPUTATIONAL SCREENING METHOD AS A TOOL TO PREDICT COCRYSTAL FORMATION OF A BCS CLASS II DRUG IBRUTINIB.
  17. DESIGN AND DEVELOPMENT OF LONG-ACTING INJECTABLE IMPLANT OF ANTI-VEGF MONOCLONAL ANTIBODY FRAGMENT IN TREATMENT OF AGE-RELATED MACULAR DEGENERATION
  18. DESIGN AND DEVELOPMENT OF NANOSTRUCTURED LIPID CARRIERS TO ENHANCE IVABRADINE HCL BIOAVAILABILITY.
  19. Design and Development of Novel Docetaxel –Loaded DQAsomes for Inducing Apoptosis and Anti-Cancer Effect on The Breast Cancer Cells, An In Vitro Study
  20. DESIGN AND DEVELOPMENT OF PH-SENSITIVE IN-SITU OPHTHALMIC GEL
  21. DESIGN AND DEVELOPMENT OF VAGINAL DRUG DELIVERY SYSTEM FOR HIV PROPHYLAXIS
  22. DESIGN AND EVALUATION OF AMLODIPINE TRANSDERMAL PATCHES
  23. Design, development and characterization of Self-microemulsifying drug delivery system (SMEDDS) of pazopanib for oral bioavailability enhancement.
  24. DESIGN, DEVELOPMENT AND EVALUATION OF ARTEMETHER-LUMEFANTRINE LOADED NANOCOCHLEATES FOR ENHANCEMENT OF ORAL BIOAVAILABILITY
  25. DEVELOPMENT AND CHARACTERIZATION OF MICROEMULSION BASED SYSTEM FOR ENHANCED PERCUTANEOUS DELIVERY THROUGH SKIN
  26. Development and Characterization of proliposomes of erlotinib for treatment of non-small cell lung cancer
  27. DEVELOPMENT AND CHARACTERIZATION OF SELF EMULSIFYING DRUG DELIVERY SYSTEM OF TENOFOVIR
  28. Development and Evaluation Keratin Based Medicated Patch for Wound Healing
  29. DEVELOPMENT AND EVALUATION OF CILNIDIPINE NANOSTRUCTURED LIPID CARRIERS AS A NOVEL DRUG DELIVERY SYSTEM FOR HYPERTENSION
  30. DEVELOPMENT AND EVALUATION OF KARANJ OIL LOADED MICROSPONGES GEL FOR MANAGEMENT OF PSORIASIS
  31. DEVELOPMENT AND EVALUATION OF MESOPOROUS SILICA NANOPARTICLES OF ROFLUMILAST
  32. DEVELOPMENT AND EVALUATION OF NANOFIBER-BASED GEL FOR TOPICAL DELIVERY OF MELOXICAM
  33. DEVELOPMENT AND EVALUATION OF ORAL DISKETTES FOR DENTAL DISORDERS OF PAEDIATRIC POPULATION
  34. Development and in-vitro characterization of Aceclofenac Hollow Microspheres by Box-Behnken Design.
  35. Development and Optimization of Nanoparticulate Drug Delivery System of Telmisartan by DoE Approach
  36. DEVELOPMENT AND OPTIMIZATION OF NOVEL MICROSPHERES FOR NASAL DELIVERY
  37. DEVELOPMENT AND OPTIMIZATION OF STERICALLY STABILIZED LIPOSOMES OF IRINOTECAN
  38. DEVELOPMENT AND PHARMACOKINETIC EVALUATION OF SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM (SMEDDS) OF CILNIDIPINE
  39. DEVELOPMENT OF ELECTROSPUN BASED OCULAR INSERT OF LEVOFLOXACIN HEMIHYDRATE FOR OPHTHALMIC DRUG DELIVERY
  40. DEVELOPMENT OF GEFITINIB LOADED MIXED MICELLES FOR PULMONARY DRUG DELIVERY
  41. DEVELOPMENT OF PEGYLATED HYBRID NANOCARRIER FOR THE TREATMENT OF DIABETES INDUCE NEURONAL COMPLICATIONS: QBD DRIVEN OPTIMIZATION, IN-VITRO RELEASE, IN-SITU ABSORPTION AND PRE-CLINICAL INVESTIGATION
  42. Development of Stable Anti-diabetic Fixed Dose Combination Drug Product with Bilayer Technology
  43. Development of taste masked orodispersible tablets of azithromycin
  44. DEVELOPMENT OF TOPICAL FILM FORMING SPRAY LOADED WITH NANOSPONGES OF PUNICALAGIN
  45. DEVELOPMENT, OPTIMIZATION AND IN VITRO EVALUATION OF MUCOADHESIVE MICROSPHERES OF BAMBUTEROL HYDROCHLORIDE FOR NASAL ADMINISTRATION
  46. DIACEREIN LOADED NANOSPONGE GEL FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
  47. DISSOLUTION METHOD DEVELOPMENT FOR CONTROLLED RELEASE DOSAGE FORM: A CASE STUDY WITH MEDICINAL REGULATORY AGENCY PERSPECTIVE
  48. ENHANCEMENT OF SPF OF KUMKUMADI TAILAM CREAM- BY FORMULATION APPROACH
  49. Enhancement of the Solubility of Lipophilic drug by Self Micro-emulsifying drug (SMEDDS) for Oral Administration
  50. ETHOSOMAL GEL FORMULATION FOR THE TREATMENT OF HYPERPIGMENTATION
  51. EXPERIMENTAL DESIGN APPROACH FOR FORMULATION OPTIMIZATION OF LUTEIN NANOCRYSTALS USING MEDIA MILLING TECHNIQUE
  52. Exploring Tamarind gum & its derivatives for ophthalmic drug delivery.
  53. EXTENDED-RELEASE TABLET OF PINDOLOL FOR TREATMENT OF HYPERTENSION
  54. FABRICATION OF CORDYCEPS MILITARIS MEDIATED GOLD NANOPARTICLES: CHARACTERIZATION AND THEIR BIOMEDICAL APPLICATIONS
  55. FACILE TECHNOLOGY FOR DESIGN OF CURCUMIN LIPOMER WITH HIGH ANTICANCER EFFICACY
  56. FAVIPIRAVIR LIPOMER
  57. FLAXSEED MUCILAGE (LINUM USITATISSIMUM L.) BASED BILAYER MUCOADHESIVE FILMS LOADED WITH DOXYCYCLINE HYCLATE AND CLOVE OIL FOR POSSIBLE TREATMENT OF PERIODONTITIS
  58. FORMULATION AND EVALUATION OF CO-CRYSTAL OF ANTIFUNGAL DRUG FOR CANDIDIASIS
  59. FORMULATION & EVALUATION OF IN SITU GEL CONTAINING DORZOLAMIDE NANOPARTICLES
  60. Formulation and Assessment of Brivaracetam containing chitosan–thioglycolic acid (TGA) conjugated Polymeric Nanoparticles for the treatment of epilepsy
  61. Formulation and Characterization of Apremilast Loaded Mesoporous Silica Nanoparticles for The Treatment of Psoriasis
  62. FORMULATION AND CHARACTERIZATION OF FLOATING MICROSPHERES OF ANTIDIABETIC DRUG
  63. Formulation and development of antiacne gel using chia seed mucilage
  64. Formulation and Evaluation of Curcumin and Quercetin loaded niosomal gel
  65. FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE FLOATING MUCOADHESIVE SYSTEM
  66. FORMULATION AND EVALUATION OF FAVIPIRAVIR PROLIPOSOMAL POWDER FOR PULMONARY DELIVERY BY NEBULIZATION
  67. FORMULATION AND EVALUATION OF FAVIPIRAVIR PRONIOSOMES FOR PULMONARY DELIVERY
  68. FORMULATION AND EVALUATION OF FLOATING MICROSPHERES OF CEFPODOXIME PROXETIL USING SIMPLE LATTICE DESIGN
  69. FORMULATION AND EVALUATION OF NANOCELLULOSE BASED TOPICAL FORMULATION
  70. FORMULATION AND EVALUATION OF SALBUTAMOL PULSINCAP DRUG DELIVERY SYSTEM
  71. FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES FOR SOLUBILITY AND PERMEABILITY ENHANCEMENT OF DIURETIC DRUG
  72. Formulation and Evaluation of Thiocolchicoside-Loaded Niosomal Gel for its Enhanced Permeation
  73. Formulation and evaluation of varenicline loaded medicated chewing gum
  74. FORMULATION AND IN-VITRO EVALUATION OF SUPER POROUS HYDROGEL AS GASTRO RETENTIVE DRUG DELIVERY SYSTEM FOR EPLERENONE
  75. FORMULATION AND IN-VITRO EVALUATION OF CLOPIDOGREL BISULPHATE NANOSUSPENSION USING BOX BEHNKEN DESIGN.
  76. FORMULATION AND OPTIMIZATION OF CURCUMIN LOADED POLYMERIC NANOSUSPENSION FOR OCULAR DRUG DELIVERY
  77. FORMULATION AND OPTIMIZATION OF NANOSTRUCTURED LIPID CARRIERS OF POORLY SOLUBLE ANTICANCER DRUG USING BOX BEHENKEN DESIGN
  78. Formulation and Optimization of Paclitaxel Loaded Lipid Nanoparticles for Oral Chemotherapy of Lung Cancer
  79. FORMULATION DEVELOPMENT AND EVALUATION OF TEMPERATURE TRIGGERED IN SITU OCULAR GEL OF CIPROFLOXACIN HYDROCHLORIDE AND OLOPATADINE HYDROCHLORIDE BY THE VALIDATED RP-HPLC METHOD
  80. FORMULATION DEVELOPMENT OF TOPICAL GEL FOR METRONIDAZOLE LOADED CHITOSAN NANOPARTICLES
  81. FORMULATION OF SOLID LIPID NANOPARTICLES (SLN)FOR TOPICAL DELIVERY OF SINAPIC ACID TO ENHANCE IT’S ANTI-INFLAMMATORY ACTIVITY.
  82. FORMULATION, DEVELOPMENT AND ANALYSIS OF BRINZOLAMIDE AND BRIMONIDINE TARTRATE NANOEMULSION FOR OCULAR DRUG DELIVERY
  83. FORMULATION, DEVELOPMENT AND EVALUATION OF HERBAL TOOTH PASTE FOR ORAL HYGIENE
  84. FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION OF IN SITU GEL FOR NASAL ADMINISTRATION
  85. Formulation, Optimization and Characterization of anti-inflammatory liquid crystalline cream using oil of Semecarpus anacardium Linn (Bhilawa)
  86. FORMULATION, OPTIMIZATION AND CHARACTERIZATION OF SNEOPT FOR ORAL DELIVERY IN THE MANAGEMENT OF GOUT
  87. GEMCITABINE HYDROCHLORIDE LOADED NANOCOCHLEATES: FORMULATION DEVELOPMENT, OPTIMIZATION, AND IN-VITRO EVALUATION
  88. HARNESSING THE THERMORESPONSIVE POLYMERS TO CONTROL THE DRUG RELEASE FROM SOLID LIPID NANOPARTICLES: A PROOF OF CONCEPT STUDY
  89. HIV integrase inhibitor loaded lipomers: formulation,optimization, kinetics and efficacy study
  90. Human serum albumin-based nanoparticles for the delivery of Oleanolic Acid and Docetaxel as a combination therapy for the treatment of triple negative breast cancer
  91. IDENTIFYING THE OPTIMIZED REACTION CONDITION AND STRUCTURAL PROPERTIES OF MESOPOROUS SILICA NANOPARTICLES THROUGH STATISTICAL DESIGN FOR THE DESIRED DRUG DELIVERY APPLICATION
  92. IMPACT OF LIPID NANOCAPSULE SURFACE-FUNCTIONALIZATION WITH NFL PEPTIDE ON ITS INTERNALIZATION IN HUMAN GLIOBLASTOMA CELLS: IN VITRO AND IN VIVO EVALUATION
  93. IMPROVED BIOAVAILABILITY OF CILNIDIPINE BY SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM
  94. IN VITRO RELEASE BEHAVIOR AND STABILITY OF BIOACTIVE LOADED SURFACE-MODIFIED NANOSTRUCTURED LIPID CARRIER
  95. INDOCYANINE GREEN DECORATED GOLD NANORODS FOR PHOTODYNAMIC AND PHOTOTHERMAL COMBINATION THERAPY OF ORAL CANCER
  96. INFLUENCE OF CHEMICAL PERMEATION ENHANCERS ON TRANSDERMAL DELIVERY OF CYCLOSPORINE A
  97. IN-SITU GEL OF PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE FOR INTRANASAL DELIVERY: In-vitro and In-vivo Studies
  98. Lawsone loaded spanlastic nanovesicles for treatment of onychomycosis
  99. Liqui-pellet technology to enhance solubility and dissolution rate of candesartan cilexetil
  100. LISOFYLLINE-FATTY ACIDS BIOCONJUGATE: SYNTHESIS, CHARACTERISATION & IN-VIVO EVALUATION OF NANOPARTICULATE TABLET IN DIABETES
  101. Mesoporous Silica Nanoparticles Functionalized with Folic Acid for Targeted Delivery of Lawsone
  102. Microspheres of Ketoconazole by using piperine as bioenhancer
  103. Multifunctional graphene oxide Nanomedicine for breast cancer therapy
  104. NIR-Activatable Hypoxia Reversing Chemo-Photodynamic Therapy for Oral Cancer
  105. Novel Natural Deep Eutectic Solvents (NDESs) systems to elicit solubility and bioavailability of Naringin: Proof of Concept
  106. NOVEL SELF EMULSIFYING COMPOSITION OF POORLY SOLUBLE POSACONAZOLE
  107. NUTRACEUTICAL GRANULES OF AQUEOUS EXTRACT OF MORINGA OLEIFERA: SUPPLEMENT FOR LACTATING MOTHER
  108. OLAPARIB @ HSA NANOPARTICLES: A PROMISING TREATMENT CHOICE FOR TRIPLE-NEGATIVE BREAST CANCER
  109. OPTIMIZATION OF PRODUCTION MEDIUM FOR SECONDARY METABOLITE PRODUCED BY SOIL ACTINOMYCETES
  110. PASTILLATION WITH AMORPHOUS POLYMERS: A CASE STUDY
  111. PHYTOSOME BASED DRY POWDER OF HERBAL DRUGS FOR THERMOGENESIS INDUCED WEIGHT LOSS.
  112. Polymeric Dissolving microneedles for transepidermal delivery of Iloperidone: In-vitro and In-vivo studies
  113. POLYMERIC MICELLER TECHNOLOGY FOR ENHANCED OCULAR DRUG DELIVERY
  114. Preparation and characterization of nanocurcumin based anti-rheumatoid formulation
  115. PREPERATION AND EVALUATION OF SILVER NANOPARTICLES FOR ANTIDIABETIC ACTIVITY USING GINGER AND GARLIC EXTRACT
  116. PROCESS OPTIMIZATION FOR LIPIDIC NANOFORMULATION OF ANTI-VEGF DRUG USING EXPERIMENTAL DESIGN FOR TREATMENT OF ORAL CANCER
  117. PROLIPOSOMAL GEL FORMULATION OF DAPSONE FOR BETTER STABILITY
  118. PRONIOSOMAL TRANSDERMAL DELIVERY OF AGOMELATINE FOR ANTIDEPRESSANT ACTIVITY
  119. QBD: FORMULATION AND PROCESS OPTIMIZATION OF GRANULES FOR TABLET COMPRESSION
  120. QUALITY BY DESIGN DRIVEN FORMULATION OF GEL FOR TOPICAL MANAGEMENT OF WOUND
  121. QUANTIFICATION OF EFAVIRENZ WITH BOOSTER DOSE OF RITONAVIR IN PEGYLATED PAMAM G4 NANOCARRIERS: PHARMAKOKINETIC, TISSUE DISTRIBUTION AND TOXICITY STUDIES IN RAT
  122. QUICK DISINTEGRATING FILM SPRINKLE ON FRUITS FOR PAEDIATRIC USE
  123. Repurposing of Linagliptin as Anti-Diabetic to Anti-Alzheimer’s
  124. RUTIN LOADED POROUS POLYMERIC VESICLES: PREPARATION AND OPTIMIZATION
  125. Solid Dispersion Adsorbate for Improved Dissolution and Flow Properties of Efavirenz: Characterization Using Factorial Design
  126. SOLUBILITY AND DISSOLUTION RATE ENHANCEMENT OF ROSUVASTATIN CALCIUM BY ADVANCED TECHNIQUES
  127. SOLUBILITY ENHANCEMENT OF HIGH MELTING AND POOR GLASS FORMER NICLOSAMIDE USING POLY-VINYL ALCOHOL BY HOT MELT EXTRUSION
  128. SOLUBILITY ENHANCEMENT THROUGH CRYSTAL ENGINEERING
  129. SPATIAL 3D INVERSE SUBSTRATES OF POLYMERIC BLENDS AND INFLUENCE OF ANTI-CANCER DRUG ON CELLULAR REGENERATION AND PROLIFERATION
  130. STABILITY STUDIES OF COCRYSTALS OF MEFLOQUINE HYDROCHLORIDE
  131. STATISTICALLY ENGINEERED PACLITAXEL NANOPARTICLE LOADED STIMULI-SENSITIVE GEL FOR IMPROVED THERAPEUTIC OUTCOME
  132. Supersaturation: A strategy to improve drug release for Rilpivirine with aid of precipitation inhibitors.
  133. SURFACE SPIKING OF LACTOFERRINE ON THE NANOSTRACTUURED LIPID CARRIERS: NOSE TO BRAIN TARGETING FOR PARKINSON’S DISEASE
  134. Systematic development and in-vitro evaluation of docetaxel loaded RAW 264.7 derived exosomes for anti-migratory effect in breast cancer
  135. Targeted Delivery of Nintedanib Surface Modified Nanostructured Lipid Carriers for Treatment of Idiopathic Pulmonary Fibrosis
  136. TRANSDERMAL DRUG DELIVERY OF ATORVASTATIN LOADED GLYCEROSOMES: IN-VITRO AND EX VIVO EVALUATION
  137. TRANSFERSOMAL GEL OF MICONAZOLE NITRATE FOR VAGINAL CANDIDIASIS
  138. TREATMENT OF ACNE VULGARIS USING DAPSONE-LOADED MIXED MICELLAR GEL
  139. VAGINAL BILAYER TABLET FOR SUSTAINED RELEASE OF ANTIFUNGAL DRUG
  140. Vitamin A-Conjugated Polymeric Micellar Systems as Doxorubicin Delivery Platform and Combination Chemotherapy for Breast Cancer